Neurobiological correlates of auditory processing in health and disease: an RDoC study
健康和疾病中听觉处理的神经生物学相关性:一项 RDoC 研究
基本信息
- 批准号:9080754
- 负责人:
- 金额:$ 73.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-16 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:22q11 Deletion SyndromeAmphetaminesAuditoryAuditory PerceptionAuditory areaAuditory systemBehaviorBloodBlood specimenCandidate Disease GeneCategoriesClinicalCorpus striatum structureDNADSM-IVDSM-VDelusional disorderDelusionsDiagnosticDiagnostic and Statistical Manual of Mental DisordersDisabled PersonsDiseaseDistressDopamineDopamine AntagonistsDopamine ReceptorEquipment and supply inventoriesExhibitsFunctional Magnetic Resonance ImagingFunctional disorderGene Expression ProfileGenesGeneticGlobus PallidusGlutamatesHallucinationsHealthIndividualLeadLearningMagnetic Resonance SpectroscopyMeasuresMidbrain structureModalityModelingMolecularMorphologyMultimodal ImagingMutationN-MethylaspartateNational Institute of Mental HealthNeurobiologyNeurocognitivePathway interactionsPatientsPerceptionPerceptual disturbancePhenotypePlayPositron-Emission TomographyProcessPsychotic DisordersRecruitment ActivityReportingResearch Domain CriteriaRestRisk FactorsRoleSamplingSchizoaffective DisordersSchizophreniaSensorySensory ProcessSeveritiesSignal TransductionStimulusSymptomsSynaptic plasticitySyndromeSystemTemporal LobeTestingThalamic structureTinnitusVerbal Auditory HallucinationsWaterWorkauditory discriminationbasecognitive systemexome sequencinggenome sequencinghandicapping conditionhippocampal pyramidal neuronhuman subjectimprovedinterdisciplinary approachmouse modelneural correlateneuroimagingnovelperipheral bloodpublic health relevancerelating to nervous systemresponsesensory mechanismtooltranscriptome sequencingtransmission processtreatment strategywhole genome
项目摘要
DESCRIPTION (provided by applicant): This proposal focuses on the role of auditory perception, a subconstruct within the cognitive systems domain of the Research Domain Criteria (RDoC), in the pathophysiology of auditory perceptual disturbances in health and across traditional (DSM-IV and DSM-V) disease categories. The overall aim is to characterize the neurobiological and neurocomputational basis of auditory sensory learning to identify pathophysiological mechanisms leading to auditory perceptual disturbances and, specifically, auditory verbal hallucinations (AVH). We aim to recruit the following groups: schizophrenia and schizoaffective disorder with low- and high-severity AVH (n=15 and n=15, respectively), delusional disorder (delusional psychosis without AVH; n=15), tinnitus (auditory perceptual disturbances without AVH; n=15), and matched healthy controls (varying degrees of subclinical perceptual disturbances; n=30). We will obtain extensive clinical, neurocognitive, and genetic characterization, and multimodal imaging in all subjects: (1) PET measures of D2/3 receptors and DA storage/release capacity within the thalamus, striatum, and the midbrain, using [11C]PHNO and the amphetamine paradigm; (2) Model-based fMRI measures of sensory prediction-error signals in auditory regions during a probabilistic, auditory discrimination task; 3) MR spectroscopy measures of glutamate concentration in the auditory cortex; (4) Task-based and resting- state fMRI connectivity measures in sensory thalamo-cortical projections; (5) Whole genome sequencing based on blood DNA samples. We will test in the overall sample across diagnostic groups if auditory PE deficits predict AVH (SA1) and correlate with altered DA in striatum and thalamus (SA2) and with increased glutamate in the auditory cortex (SA3). We will also explore the relationship within the same subjects between DA and glutamate (EA1) and the relationships of auditory PE to connectivity between auditory thalamus and auditory cortex (EA2) and identify a set of candidate genes associated with auditory PE deficits (EA3). This RDoC proposal will lead to further understanding of the mechanisms of sensory learning and their perturbations in conditions associated with auditory perceptual alterations.
描述(由适用提供):该提案着重于听觉感知的作用,这是研究领域标准的认知系统领域(RDOC)在健康和传统(DSM-IV和DSM-V)疾病中的听觉感知障碍的病理生理学中。总体目的是表征听觉感觉学习的神经生物学和神经计算基础,以鉴定导致听觉感知障碍的病理生理机制,尤其是听觉口语幻觉(AVH)。我们旨在招募以下组:具有低度和高度AVH(分别为n = 15和n = 15)的精神分裂症和精神分裂症(分别为n = 15和n = 15),妄想障碍(没有AVH的妄想精神;亚临床感知疾病的程度; n = 30)。我们将在所有受试者中获得广泛的临床,神经认知和遗传表征以及多模式成像:(1)使用[11C] Phno和Amphetamine paradigm在丘脑,纹状体和中脑内的D2/3受体和DA存储/释放能力的PET测量; (2)基于模型的fMRI测量在概率,听觉歧视任务期间,听觉区域中的感觉预测信号; 3)听觉皮层中谷氨酸浓度的MR光谱测量; (4)在感觉thalammo-cortical投影中基于任务和静止状态fMRI连接度量; (5)基于血液DNA样品的整个基因组测序。如果听觉PE定义了预测AVH(SA1),并且与纹状体和丘脑(SA2)(SA2)(SA2)中的DA相关,并且与听觉皮层(SA3)中的谷氨酸增加,我们将在诊断组的总体样本中进行测试。我们还将探讨DA和谷氨酸(EA1)之间相同主题的关系,以及听觉PE与听觉丘脑与听觉皮层(EA2)之间的连通性的关系,并识别一组与听觉PE相关的候选基因(EA3)。该RDOC建议将进一步了解与听觉感知改变有关的感觉学习机制及其在扰动中的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anissa Abi-Dargham其他文献
Anissa Abi-Dargham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anissa Abi-Dargham', 18)}}的其他基金
Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
深度 rTMS 调节精神分裂症患者的岛叶突触密度和吸烟行为
- 批准号:
10710181 - 财政年份:2022
- 资助金额:
$ 73.25万 - 项目类别:
Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
深度 rTMS 调节精神分裂症患者的岛叶突触密度和吸烟行为
- 批准号:
10494515 - 财政年份:2022
- 资助金额:
$ 73.25万 - 项目类别:
Preliminary imaging studies of the kappa opioid receptors in schizophrenia and their relationship to dopamine function
精神分裂症κ阿片受体及其与多巴胺功能关系的初步影像学研究
- 批准号:
10304170 - 财政年份:2020
- 资助金额:
$ 73.25万 - 项目类别:
Probing dopamine D2 receptor trafficking in schizophrenia
探索精神分裂症中的多巴胺 D2 受体贩运
- 批准号:
8712557 - 财政年份:2013
- 资助金额:
$ 73.25万 - 项目类别:
Probing dopamine D2 receptor trafficking in schizophrenia
探索精神分裂症中的多巴胺 D2 受体贩运
- 批准号:
8584066 - 财政年份:2013
- 资助金额:
$ 73.25万 - 项目类别:
RC2 Alcohol-induced human striatal dopamine release related to alcoholism vulnera
RC2 酒精诱导的人纹状体多巴胺释放与酒精中毒伤病相关
- 批准号:
8128248 - 财政年份:2011
- 资助金额:
$ 73.25万 - 项目类别:
相似国自然基金
杏仁核PTEN参与甲基苯丙胺成瘾记忆调控的机制研究
- 批准号:82301676
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腹侧被盖区多巴胺神经元投射偏向性对甲基苯丙胺自给药个体差异的影响及其机制
- 批准号:32300846
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GPR37与多巴胺D2受体相互作用调控甲基苯丙胺成瘾的机制研究
- 批准号:82302127
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
大麻二酚通过环状RNAcircDennd1b/mi183-5p/KCNJ5轴干预甲基苯丙胺依赖的机制研究
- 批准号:82360336
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
甜菜碱调控Th17细胞分化参与甲基苯丙胺所致精神障碍的机制研究
- 批准号:82371899
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Pharmacologic augmentation of targeted cognitive training in schizophrenia
精神分裂症针对性认知训练的药物增强
- 批准号:
10231201 - 财政年份:2020
- 资助金额:
$ 73.25万 - 项目类别:
Pharmacologic augmentation of targeted cognitive training in schizophrenia
精神分裂症针对性认知训练的药物增强
- 批准号:
10039026 - 财政年份:2020
- 资助金额:
$ 73.25万 - 项目类别:
Pharmacologic augmentation of targeted cognitive training in schizophrenia
精神分裂症针对性认知训练的药物增强
- 批准号:
10460954 - 财政年份:2020
- 资助金额:
$ 73.25万 - 项目类别:
Heterogeneous HPC changes alter context processing in MAM model of schizophrenia
异质 HPC 变化改变了精神分裂症 MAM 模型的上下文处理
- 批准号:
8969297 - 财政年份:2015
- 资助金额:
$ 73.25万 - 项目类别:
A D1 Agonist for Working Memory Enhancement in the Schizophrenia Spectrum
D1 激动剂可增强精神分裂症患者的工作记忆
- 批准号:
8506077 - 财政年份:2013
- 资助金额:
$ 73.25万 - 项目类别: